MGRX — Mangoceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- $7.74m
- $7.57m
- $0.46m
Annual cashflow statement for Mangoceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.018 | -2 | -9.21 | -8.71 | -20.6 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 0 | 0.629 | 2.15 | 2.39 | 13.3 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0 | 0.019 | 0.042 | 0.72 | -0.201 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -0.018 | -1.35 | -7 | -4.86 | -5.85 |
| Capital Expenditures | 0 | -0.043 | -0.004 | — | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | — | 0.065 | — |
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | 0 | -0.043 | -0.004 | 0.065 | — |
| Financing Cash Flow Items | — | — | — | — | 1.15 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.04 | 2.05 | 7.06 | 4.13 | 7.27 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.023 | 0.66 | 0.056 | -0.68 | 1.43 |